Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2010

Sep 8, 2010

30786_dirs_2010-09-08_77334892-0155-49c0-9eeb-e6b2a2d1fe7d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2010-09-03

Reporting Person: SCHWARTZ DAVID (Director, Chairman of the Board, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-09-03 Bio-Rad B Common Stock M 36250 $11.94 Acquired 426640 Direct
2010-09-07 Bio-Rad B Common Stock M 36250 $11.94 Acquired 462890 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-09-03 Non-Qualified Stock Option (right to buy) $11.94 M 36250 Disposed 2010-09-19 Bio-Rad B Common Stock (36250) Direct
2010-09-07 Non-Qualified Stock Option (right to buy) $11.94 M 36250 Disposed 2010-09-19 Bio-Rad B Common Stock (36250) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 1404588 Direct
Bio-Rad A Common Stock 825208 Indirect
Bio-Rad A Common Stock 825208 Indirect
Bio-Rad A Common Stock 34311 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 41176 Indirect

Footnotes

F1: The shares are held by a limited partnership of which the reporting person is a limited and general partner.

F2: The shares are held by a limited partnership of which the reporting person is a general partner.

F3: The stock option, granted on 9/19/2000, vested over four years at 25% per year on the yearly anniversary date of the grant.